• Net profit was down 10.1% YoY at ₹7,941.4 cr. • Revenue was up 2.5% YoY at ₹35,983.2 cr. • EBITDA was down 14.5% YoY at ₹10,513.8 cr. • Margin at 29.1% vs 34.9.5% (YoY).

Lupin's arm received USFDA approval for Fluocinolone Acetonide Body Oil which used to treat Eczema.

• Net profit was up 12.2% YoY at ₹120.6 cr. • Revenue up 2.6% YoY at ₹347.6 cr.